PAPER
Reconstructed Hydrotalcites in the Synthesis of 2-Benzimidazolethiols
3285
Monoalkylated 2-Benzimidazolethiols 2–5; General Procedure
A mixture of HTr (135 mg) in EtOH (7 mL) was placed in a micro-
wave tube having a magnetic stirrer. Subsequently, 2-benzimid-
azolethiol (1) (510 mg, 3.4 mmol) and an alkyl halide (3.4 mmol)
were added to the mixture, which was heated under microwave ir-
radiation (30 W, 70 °C, simultaneous air cooling) for the time given
in Table 2, entry 8, or Table 3. Then, HTr was filtered off and
washed with EtOH (10–15 mL). The EtOH used to wash the HTr
was combined with the filtered reaction mixture and the whole was
vacuum evaporated, and the residue was purified by column chro-
matography (EtOAc–hexanes, 20:80, 10:90, or 5:95) and/or recrys-
tallization (EtOH–H2O, 1:1).
13C NMR (125.7 MHz, DMSO-d6): δ = 34.4 (SCH2), 110.8 (ArCH),
117.9 (ArCH), 118.9 (=CH2), 121.9 (2 ArCH), 134.3 (=CH), 136.0
(Cipso), 144.2 (Cipso), 149.9 (N=C–S).
Dialkylated 2-Benzimidazolethiols 6–10; General Procedure
A mixture of HTr (260 mg) in EtOH (7 mL) was placed in a micro-
wave tube having a magnetic stirrer. Subsequently, 2-benzimid-
azolethiol (1) (0.51 g, 3.4 mmol) and an alkyl halide (7.9 mmol)
were added to the mixture, which was heated under microwave ir-
radiation [30 W, 70 °C, simultaneous air cooling, except in the case
of the formation of 9 (see below)] for the time given in Table 4.
Then, HTr was filtered off and washed with EtOH (10–15 mL). The
EtOH used to wash the HTr was combined with the filtered reaction
mixture and the whole was vacuum evaporated, and the residue was
purified by column chromatography (EtOAc–hexanes, 20:80,
10:90, or 5:95) and recrystallization (EtOH–H2O, 1:1).
2-(Benzylthio)-1H-benzimidazole (2)
The title compound was prepared from 1 (510 mg, 3.4 mmol) and
benzyl chloride (0.39 mL, 3.4 mmol) according to the above general
procedure.
1-Benzyl-2-(benzylthio)-1H-benzimidazole (6)
The title compound was prepared from 1 (0.51 g, 3.4 mmol) and
benzyl chloride (0.91 mL, 7.9 mmol) according to the above general
procedure.
Yield: 790 mg (98%); white solid; mp 183–184 °C (Lit.24 184–185
°C).
1H NMR (400 MHz, DMSO-d6): δ = 4.57 (s, 2 H, SCH2), 7.09–7.14
(m, 2 H, ArH), 7.21–7.32 (m, 3 H, ArH), 7.43–7.45 (m, 4 H, ArH),
12.58 (br s, 1 H, NH).
13C NMR (100.5 MHz, DMSO-d6): δ = 35.7 (SCH2), 111.0 (ArCH),
118.0 (ArCH), 122.0 (2 ArCH), 127.9 (ArCH), 129.0 (2 ArCH),
129.4 (2 ArCH), 136.0 (Cipso), 138.3 (Cipso), 144.2 (Cipso), 150.3
(N=C–S).
Yield: 790 mg (71%); white solid; mp 85–86 °C (Lit.27 93–93.5 °C).
1H NMR (500 MHz, CDCl3): δ = 4.64 (s, 2 H, SCH2), 5.23 (2 H,
NCH2), 7.09–7.12 (m, 2 H, ArH), 7.17–7.19 (m, 2 H, ArH), 7.22–
7.33 (m, 7 H, ArH), 7.39–7.43 (m, 2 H, ArH), 7.76 (d, J = 8.05 Hz,
1 H, ArH).
13C NMR (125.7 MHz, CDCl3): δ = 37.6 (SCH2), 47.7 (NCH2),
109.4 (ArCH), 118.6 (ArCH), 122.2 (ArCH), 122.3 (ArCH), 127.0
(2 ArCH), 127.8 (ArCH), 128.0 (ArCH), 128.8 (2 ArCH), 128.9 (2
ArCH), 129.2 (2 ArCH), 135.7 (Cipso), 136.3 (Cipso), 136.7 (Cipso),
143.7 (Cipso), 151.8 (N=C–S).
2-(4-Chlorobenzylthio)-1H-benzimidazole (3)
The title compound was prepared from 1 (510 mg, 3.4 mmol) and
4-chlorobenzyl chloride (540 mg, 3.4 mmol) according to the above
general procedure.
Yield: 800 mg (98%); white solid; mp 179–180 °C (Lit.25 180–181
°C).
1H NMR (500 MHz, DMSO-d6): δ = 4.52 (s, 2 H, SCH2), 7.06–7.12
(m, 2 H, ArH), 7.31–7.34 (m, 2 H, ArH), 7.36–7.48 (m, 4 H, ArH),
12.56 (br s, 1 H, NH).
1-(4-Chlorobenzyl)-2-(4-chlorobenzylthio)-1H-benzimidazole
(7)
The title compound was prepared from 1 (0.51 g, 3.4 mmol) and 4-
chlorobenzyl chloride (1.27 g, 7.9 mmol) according to the above
general procedure.
13C NMR (125.7 MHz, DMSO-d6): δ = 34.8 (SCH2), 110.9 (ArCH),
117.9 (ArCH), 122.0 (2 ArCH), 128.9 (2 ArCH), 131.2 (2 ArCH),
132.4 (Cipso), 136.2 (Cipso), 137.6 (Cipso), 144.2 (Cipso), 149.9 (N=C–
S).
Yield: 790 mg (75%); white solid; mp 74–75 °C.
IR (neat): 3053, 3024, 2919, 1713, 1490, 1322, 1092, 795, 734 cm–1.
1H NMR (500 MHz, DMSO-d6): δ = 4.58 (s, 2 H, SCH2), 5.32 (s, 2
H, NCH2), 7.06 (d, J = 8.5 Hz, 2 H, ArH), 7.11–7.17 (m, 2 H, ArH),
7.28–7.33 (m, 4 H, ArH), 7.40–7.45 (m, 3 H, ArH), 7.57–7.60 (m,
1 H, ArH).
13C NMR (125.7 MHz, DMSO-d6): δ = 35.5 (SCH2), 46.5 (NCH2),
110.4 (ArCH), 118.4 (ArCH), 122.4 (ArCH), 122.6 (ArCH), 128.9
(2 ArCH), 129.2 (2 ArCH), 129.3 (2 ArCH), 131.3 (2 ArCH), 132.6
(Cipso), 132.8 (Cipso), 135.8 (Cipso), 136.6 (Cipso), 137.3 (Cipso), 143.5
(Cipso), 151.3 (N=C–S).
2-(2-Pyridinylmethylthio)-1H-benzimidazole (4)
The title compound was prepared from 1 (510 mg, 3.4 mmol) and
2-pyridinylmethyl chloride hydrochloride (550 mg, 3.4 mmol) ac-
cording to the above general procedure.
Yield: 770 mg (94%); white solid; mp 100–101 °C (Lit.26 100–102
°C).
1H NMR (500 MHz, CDCl3): δ = 4.41 (s, 2 H, SCH2), 7.16–7.20 (m,
2 H ArH), 7.22–7.26 (m, 1 H, ArH), 7.35 (d, J = 7.8 Hz, 1 H, ArH),
7.54 (br s, 2 H, ArH), 7.67 (td, J = 7.7, 1.7 Hz, 1 H, ArH), 8.60 (d,
J = 4.3 Hz, 1 H, ArH), 13.04 (br s, 1 H, NH).
13C NMR (125.7 MHz, CDCl3): δ = 38.1 (SCH2), 110.7 (ArCH),
118.3 (ArCH), 122.1 (2 ArCH), 123.0 (ArCH), 123.8 (ArCH),
135.3 (Cipso), 138.0 (ArCH), 144.1 (Cipso), 149.1 (ArCH), 151.1
(N=C–S), 158.0 (Cipso).
HRMS-ESI-TOF: m/z [M + H]+ calcd for C21H16Cl2N2S: 399.0484;
found: 399.0487.
1-(2-Pyridinylmethyl)-2-(2-pyridinylmethylthio)-1H-benzimid-
azole (8)
The title compound was prepared from 1 (0.51 g, 3.4 mmol) and 2-
pyridinylmethyl chloride hydrochloride (1.29 g, 7.9 mmol) accord-
ing to the above general procedure.
Yield: 688 mg (61%); white solid; mp 81–82 °C.
2-(Allylthio)-1H-benzimidazole (5)
The title compound was prepared from 1 (510 g, 3.4 mmol) and allyl
bromide (0.29 mL, 3.4 mmol) according to the above general pro-
cedure.
Yield: 830 mg (77%); white solid; mp 134–135 °C (Lit.25 133.5–
135 °C).
1H NMR (500 MHz, DMSO-d6): δ = 3.91–3.93 (m, 2 H, SCH2),
5.05–5.08 (m, 1 H, =CH2), 5.25–5.30 (m, 1 H, =CH2), 5.92–6.01
(m, 1 H, =CH), 7.06–7.10 (m, 2 H, ArH), 7.41 (br s, 2 H, ArH),
12.52 (br s, 1 H, NH).
IR (neat): 3053, 3010, 2954, 2932, 1588, 1565, 1478, 1419, 985,
737 cm–1.
1H NMR (500 MHz, CDCl3): δ = 4.79 (s, 2 H, SCH2), 5.38 (s, 2 H,
NCH2), 6.77 (d, J = 7.85 Hz, 1 H, ArCH), 7.12–7.23 (m, 5 H,
ArCH), 7.45–7.50 (m, 2 H, ArCH), 7.56–7.60 (m, 1 H, ArCH),
7.70–7.73 (m, 1 H, ArCH), 8.52–8.56 (m, 2 H, ArCH).
13C NMR (125.7 MHz, CDCl3): δ = 39.0 (SCH2), 49.5 (NCH2),
109.5 (ArCH), 118.5 (ArCH), 121.0 (ArCH), 122.3 (ArCH), 122.4
(ArCH), 122.5 (ArCH), 122.8 (ArCH), 123.5 (ArCH), 136.4 (Cipso),
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2013, 45, 3281–3287